SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-002334
Filing Date
2020-03-10
Accepted
2020-03-10 17:17:37
Documents
103
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ptgx-20191231x10k.htm 10-K 3295587
2 EX-4.7 ptgx-20191231ex4743c3fa2.htm EX-4.7 27696
3 EX-10.25 ptgx-20191231ex1025844a2.htm EX-10.25 1081940
4 EX-21.1 ptgx-20191231ex211305722.htm EX-21.1 3774
5 EX-23.1 ptgx-20191231ex231a1fa11.htm EX-23.1 4212
6 EX-31.1 ptgx-20191231ex311dfbc23.htm EX-31.1 12057
7 EX-31.2 ptgx-20191231ex3125360c1.htm EX-31.2 12028
8 EX-32.1 ptgx-20191231ex32128912a.htm EX-32.1 12112
9 GRAPHIC ptgx20191231ex1025844a2001.jpg GRAPHIC 16108
10 GRAPHIC ptgx20191231x10k001.jpg GRAPHIC 68006
11 GRAPHIC ptgx20191231x10k002.jpg GRAPHIC 57942
12 GRAPHIC ptgx20191231x10k003.jpg GRAPHIC 52601
13 GRAPHIC ptgx20191231x10k004.jpg GRAPHIC 42964
14 GRAPHIC ptgx20191231x10k005.jpg GRAPHIC 41677
  Complete submission text file 0001558370-20-002334.txt   13243190

Data Files

Seq Description Document Type Size
15 EX-101.INS ptgx-20191231.xml EX-101.INS 2651049
16 EX-101.SCH ptgx-20191231.xsd EX-101.SCH 75468
17 EX-101.CAL ptgx-20191231_cal.xml EX-101.CAL 83583
18 EX-101.DEF ptgx-20191231_def.xml EX-101.DEF 240271
19 EX-101.LAB ptgx-20191231_lab.xml EX-101.LAB 609560
20 EX-101.PRE ptgx-20191231_pre.xml EX-101.PRE 520908
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37852 | Film No.: 20702966
SIC: 2834 Pharmaceutical Preparations